![](/img/cover-not-exists.png)
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study
G. Tarantino, P. Sorrentino, P. Conca, A. Perrella, P. Ragucci, O. PerrellaVolume:
23
Year:
2003
Language:
english
Pages:
7
DOI:
10.1111/j.1478-3231.2003.00871.x
File:
PDF, 128 KB
english, 2003